---
schema_version: "secwatch.filing_event.v1"
accession: "0000874716-23-000143"
form_type: "8-K"
ticker: "IDXX"
cik: "0000874716"
company_name: "IDEXX LABORATORIES INC /DE"
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:39:57.484584+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# IDEXX EVP and Chief Commercial Officer James Polewaczyk to retire April 1, 2024

## Summary
- James F. Polewaczyk, EVP and Chief Commercial Officer, notified retirement on Dec 5, 2023.
- Effective date of retirement is April 1, 2024, after 17 years of service.
- No replacement has been announced; search process not disclosed.

## SEC filing metadata
- accession: 0000874716-23-000143
- form_type: 8-K
- ticker: IDXX
- cik: 0000874716
- company_name: IDEXX LABORATORIES INC /DE
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874716/000087471623000143/0000874716-23-000143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874716/000087471623000143/idxx-20231205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000874716-23-000143
- JSON: https://secwatch.observer/filing/0000874716-23-000143.json
- Plain text: https://secwatch.observer/filing/0000874716-23-000143.txt

## Key facts
- Executive change
  James F. Polewaczyk departed as Executive Vice President and Chief Commercial Officer at IDEXX LABORATORIES INC /DE.
  - Action: notified his intent to retire
  - Role: Executive Vice President and Chief Commercial Officer
  source text: On December 5, 2023, James F. Polewaczyk, Executive Vice President and Chief Commercial Officer of IDEXX Laboratories, Inc. (the “Company”), notified the Company of his intent to retire after more than 17 years of dedicated leadership and service, effective April 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/874716/000087471623000143/0000874716-23-000143-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.